JAK2 inhibitors and myeloproliferative neoplasms.
Verstovsek
Srdan
S
Leukemia Department, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.
D004351:Drug Resistance; D004795:Enzyme Stability; D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology
D053614:Janus Kinase 2